Article Per Year (5 Year)
p-Index From 2019 - 2024
0.61
P-Index
This Author published in this journals
All Journal Ophthalmologica Indonesiana Ophthalmologica Indonesiana
Rini Sulastiwaty
Unknown Affiliation
Health Professions Medicine & Pharmacology Physics Public Health

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 3 Documents
Search

 1 
The Short-Term Efficacy and Safety of iStent Implantation Combined With Cataract Extraction on Lowering The Intraocular Pressure in Patients with Glaucoma: A Pilot Study in Indonesia Rini Sulastiwaty; Q Syahril
Majalah Oftalmologi Indonesia Vol 47 No 1 (2021): Ophthalmologica Indonesiana
Publisher : The Indonesian Ophthalmologists Association (IOA, Perhimpunan Dokter Spesialis Mata Indonesia (Perdami))

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35749/journal.v47i1.100153

Abstract

Introduction: Minimally invasive glaucoma surgery (MIGS) is continuously being improved after it was first initiated in the early 2000s. This promising method is hoped to fill the gap between medication and traditional surgeries in management of glaucoma.Objective: To evaluate the efficacy and safety of iStents implantation combined with cataract extraction in managing intraocular pressure in glaucoma patients. Methods: We collected data from 6 eyes of 5 patients with POAG and cataract pre-operatively. The extraction of cataract was then performed, combined with second generation iStents implantation. The follow up procedure included the change of intra ocular pressure (IOP), Visual acuity, and the need for IOP lowering Medication at 1 week and 1 month post-operatively. Results: There was a reduction of mean IOP from the baseline, which was 21.33 ± 6.15 to 18.0 ± 6.0 and 18.11 ± 5.57 at 1-week and 1-month following the surgery. The reduction of IOP was also followed by the reduction of medications needed for the patients. The mean visual acuity following the surgery was also increased from the baseline 0.53 ± 0.41 to 0.85 ± 0.17 at 1 – week and 0.91 ± 0.16 at 1 – month. For safety outcomes, there were no major adverse effect nor complication from the procedures after 1 month of follow up. Conclusion: The iStents implantation helped lowering the IOP of patients with glaucoma. It also reduced the need for further IOP lowering medication following the procedure.
The Short-Term Efficacy and Safety of iStent Implantation Combined With Cataract Extraction on Lowering The Intraocular Pressure in Patients with Glaucoma: A Pilot Study in Indonesia Rini Sulastiwaty; Q Syahril
Majalah Oftalmologi Indonesia Vol 47 No 1 (2021): Ophthalmologica Indonesiana
Publisher : The Indonesian Ophthalmologists Association (IOA, Perhimpunan Dokter Spesialis Mata Indonesia (Perdami))

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35749/journal.v47i1.100153

Abstract

Introduction: Minimally invasive glaucoma surgery (MIGS) is continuously being improved after it was first initiated in the early 2000s. This promising method is hoped to fill the gap between medication and traditional surgeries in management of glaucoma.Objective: To evaluate the efficacy and safety of iStents implantation combined with cataract extraction in managing intraocular pressure in glaucoma patients. Methods: We collected data from 6 eyes of 5 patients with POAG and cataract pre-operatively. The extraction of cataract was then performed, combined with second generation iStents implantation. The follow up procedure included the change of intra ocular pressure (IOP), Visual acuity, and the need for IOP lowering Medication at 1 week and 1 month post-operatively. Results: There was a reduction of mean IOP from the baseline, which was 21.33 ± 6.15 to 18.0 ± 6.0 and 18.11 ± 5.57 at 1-week and 1-month following the surgery. The reduction of IOP was also followed by the reduction of medications needed for the patients. The mean visual acuity following the surgery was also increased from the baseline 0.53 ± 0.41 to 0.85 ± 0.17 at 1 – week and 0.91 ± 0.16 at 1 – month. For safety outcomes, there were no major adverse effect nor complication from the procedures after 1 month of follow up. Conclusion: The iStents implantation helped lowering the IOP of patients with glaucoma. It also reduced the need for further IOP lowering medication following the procedure.
Management of Hypotony Maculopathy: Poster Presentation - Case Report - Ophthalmologist Sri Astri Nanditya; Asti Ayudianingrum; Rini Sulastiwaty
Majalah Oftalmologi Indonesia Vol 49 No S2 (2023): Supplement Edition
Publisher : The Indonesian Ophthalmologists Association (IOA, Perhimpunan Dokter Spesialis Mata Indonesia (Perdami))

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35749/cp4sd706

Abstract

Introduction : Hypotony is a common complicatons after glaucoma filtering surgery. Hypotony maculopathy is a serious condition that related to the significant decrease in visual acuity. This case report is to show the case of hypotony maculopathy and the risk factors. Case Illustration : A 28 yo female with juvenile glaucoma undergone trabeculectomy on her left eye. One day post surgery show significant inflamation forming fibrin in pupil area. POD 1 IOP decreased to 2 mmHg and remains hypotony after 2 weeks post surgery. Visual acuity decreased significantly even when the anterior chamber inflamation has resolved. Funduscopy showed typical appearance of hypotony maculopathy. Oral steroid of methylprednisolon 1 mg/kg per body weight, and topical prednisolon was administered since POD 1. Visual acuity gained and iop rised to 14 after 3 weeks with theraphy with oral and topical steroid. Discussion : Sudden drop of intraocular pressure may lead to many complications such as hipotony maculopathy. It was a frightening as it may decreased the visual acuity permanently. Young age and severe post operative inflamation are risk factors found in this patient. Conclusion : Hypotony after glaucoma filtering surgery may caused hypotony maculopathy. Young age and high inflamation are risk factors for developing hypotony maculopathy. Risk factors considerations and early treatment of hypotony is essential to prevent the sight threatening complications such as hypotony maculopathy.
Co-Authors Asti Ayudianingrum Q Syahril Sri Astri Nanditya